Childhood obesity and insulin-resistant syndrome

Cynthia S Yensel1, Daniel Preud'homme, Donna Miles Curry

  • 1Children's Hospital, Columbus, OH 43205, USA. yenselc@chi.osu.edu

Insights

Childhood obesity and insulin resistance syndrome (IRS) are growing concerns. Pediatric nurses are key in identifying at-risk children and implementing necessary interventions to combat these health threats.

Area of Science:

  • Pediatric Nursing
  • Public Health
  • Endocrinology

Background:

  • Childhood obesity is a significant national health concern with increasing prevalence.
  • Obesity in children is linked to numerous comorbidities persisting into adulthood.
  • Insulin-resistant syndrome (IRS) is increasingly diagnosed in obese pediatric populations.

Purpose of the Study:

  • To provide pediatric nurses with current information on identifying children at risk for obesity and IRS.
  • To outline essential tools and methods for risk assessment in pediatric obesity and IRS.
  • To detail necessary interventions for managing childhood obesity and associated IRS.

Main Methods:

  • Review of current literature and clinical guidelines on childhood obesity and IRS.
  • Identification of validated screening tools for obesity and insulin resistance in children.
  • Description of evidence-based nursing interventions for prevention and management.

Main Results:

  • Specific risk factors and screening criteria for identifying at-risk children were detailed.
  • Effective tools for assessing obesity and insulin resistance were presented.
  • A range of interventions, from lifestyle modifications to medical management, were discussed.

Conclusions:

  • Pediatric nurses are crucial in the early detection and management of childhood obesity and IRS.
  • Utilizing appropriate tools and interventions can mitigate the long-term health consequences of pediatric obesity.
  • Proactive nursing strategies are essential for addressing the rising rates of childhood obesity and IRS.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...